Tutorials
Advaxis Inc logo

Advaxis Inc

$ 3.38 -0.01 (-0.29%) 12:56 PM EST
P/E:
At Loss
P/B:
0.18
Market Cap:
$ 6.15M
Enterprise V:
$ -25.89M
Volume:
1.50K
Avg Vol (2M):
4.86K
Also Trade In:
Volume:
1.50K
Market Cap $:
6.15M
PE Ratio:
At Loss
Avg Vol (2-Month):
4.86K
Enterprise Value $:
-25.89M
PB Ratio:
0.18
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Advaxis Inc
NAICS : 325414 SIC : 2834
9 Deer Park Drive, Suite K-1, Monmouth Junction, NJ, USA, 8540
Description
Advaxis Inc is a clinical-stage biotechnology company operating in the United States. It focuses on the discovery, development, and commercialization of proprietary Lm (Listeria monocytogenes)-LLO (Listeriolysin O) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins. The company's immunotherapy products based on Lm-LLO immunotherapy are Axalimogene filolisbac (AXAL) which targets Human Papilloma Virus (HPV) - associated cancers and ADXS-PSA which targets Prostate-Specific Antigen (PSA) associated with prostate cancer.
Name Current Vs Industry Vs History
Cash-To-Debt 1188.33
Equity-to-Asset 0.94
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -14.28
Distress
Grey
Safe
Beneish M-Score -4.51
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 32.34
9-Day RSI 36.3
14-Day RSI 39.44
6-1 Month Momentum % -58.98
12-1 Month Momentum % -87.83

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 14.44
Quick Ratio 14.44
Cash Ratio 13.56
Days Sales Outstanding 1003.75

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -215.5

Financials (Next Earnings Date:2022-09-09 Est.)

ADXS's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with OTCPK:ADXS

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.5
EPS (TTM) ($) -6.9
Beta 1.53
Volatility % 85.09
14-Day RSI 39.44
14-Day ATR ($) 0.402975
20-Day SMA ($) 3.8555
12-1 Month Momentum % -87.83
52-Week Range ($) 3 - 51.6
Shares Outstanding (Mil) 1.82

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Advaxis Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More